A detailed history of Pax Financial Group, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Pax Financial Group, LLC holds 18,884 shares of AXGN stock, worth $332,736. This represents 0.05% of its overall portfolio holdings.

Number of Shares
18,884
Previous 18,884 -0.0%
Holding current value
$332,736
Previous $136,000 94.12%
% of portfolio
0.05%
Previous 0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$6.99 - $10.0 $131,999 - $188,840
18,884 New
18,884 $155,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $745M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Pax Financial Group, LLC Portfolio

Follow Pax Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pax Financial Group, LLC with notifications on news.